Closed
EUP OHAMR Joint Transnational Call
Supports One Health research on antimicrobial resistance treatment innovations
Last Update: March 4, 2026
Funding available
$ 600,000
Timeline
- Closing date : February 24, 2026
Location
Canada
Overview
This CIHR Operating Grant supports a Canadian component of a joint transnational One Health antimicrobial resistance project to advance innovative, cost-effective AMR treatment options, with up to Can$600,000 total (Can$200,000 per year for up to 3 years). Eligible activities must address Topic 3 by assessing how veterinary and agricultural use of antibacterial and antifungal drugs affects AMR emergence and transmission to humans and the environment, and improving formulations, dosage, delivery, routes of administration, and treatment regimens to inform policies restricting certain antimicrobials for exclusive human use.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Conduct research and development activities
- Conduct research or evaluation activities
Eligible Funding
- Maximum amount : 600,000 $
Timeline
- Closing date : February 24, 2026
Eligible candidates
Eligible Industries
- Agriculture, forestry, fishing and hunting
- Professional, scientific and technical services
- Health care and social assistance
Location
- Canada
Legal structures
- Non-profit
- Public or Parapublic institution
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- Indigenous Peoples
- Canadians
Non-profit candidates
Sector of operation
- All industries
Target groups
- All the groups
Revenue structures
- All structures
Scope
- All dimensions
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Joint transnational One Health research projects on antimicrobial resistance treatment options.
- Research on the impact of veterinary and agricultural antimicrobials on AMR transmission to humans and the environment.
- Projects to improve formulations, dosage, delivery, routes of administration, and treatment regimens.
- Research generating evidence to support restrictions on certain antimicrobials for human use.
Documents Needed
- One-page Research Project Summary
- Copy of the EUP OHAMR pre-proposal submitted to the Joint Call Secretariat
- Operating budget in Canadian dollars with justification
- Copy of the EUP OHAMR full proposal submitted to the Joint Call Secretariat
- SGBA training certificate for the Nominated Principal Applicant
Eligibility
Who is eligible?
- Independent researchers affiliated with Canadian postsecondary institutions and eligible affiliated institutions.
- Indigenous non-governmental organizations in Canada with research or knowledge translation mandates.
- Researchers and organizations participating in a transnational AMR consortium.
Who is not eligible
- For-profit companies (the Nominated Principal Applicant must be an independent researcher affiliated with a Canadian postsecondary institution/affiliated institution, or affiliated with/being an Indigenous non-governmental organization with a research and/or knowledge translation mandate).
- Organizations or projects focused only on animal health, plants, food and/or the environment without including human health research activities (CIHR will not fund these).
- Applicants/projects that do not address the required call topic for CIHR funding (Topic 3); proposals outside this topic will not be deemed relevant and will not receive CIHR funding.
Eligible geographic areas
- Canada
Processing and Agreement
- Applications are reviewed through the EUP OHAMR review and evaluation process.
- CIHR also conducts a relevance review using the full application.
- To be deemed relevant, the project must align with CIHR’s mandate, Topic 3, and human health.
- Successful applicants are published on the CIHR website.
Additional information
- The Joint Call Secretariat hosted a webinar for applicants on November 26, 2025.
- CIHR provides a Partner Linkage Tool to help connect researchers with potential partners.
- All applicants must meet both joint and national requirements.
Contacts
Frequently Asked Questions about the EUP OHAMR Joint Transnational Call Program
Here are answers to the most common questions about the EUP OHAMR Joint Transnational Call. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.
What is the EUP OHAMR Joint Transnational Call?
This CIHR Operating Grant supports a Canadian component of a joint transnational One Health antimicrobial resistance project to advance innovative, cost-effective AMR treatment options, with up to Can$600,000 total (Can$200,000 per year for up to 3 years). Eligible activities must address Topic 3 by assessing how veterinary and agricultural use of antibacterial and antifungal drugs affects AMR emergence and transmission to humans and the environment, and improving formulations, dosage, delivery, routes of administration, and treatment regimens to inform policies restricting certain antimicrobials for exclusive human use.
How much funding can be received?
EUP OHAMR Joint Transnational Call Funds up to $600,000 of admissible expenses.
Who is eligible for the EUP OHAMR Joint Transnational Call program?
To be eligible for the EUP OHAMR Joint Transnational Call program, you must:
Canadian research or Indigenous mandate.
Role must remain in Canada.
Must meet CIHR Topic 3 and human health focus.
What expenses are eligible under EUP OHAMR Joint Transnational Call?
Joint transnational One Health research projects on antimicrobial resistance treatment options.
Research on the impact of veterinary and agricultural antimicrobials on AMR transmission to humans and the environment.
Projects to improve formulations, dosage, delivery, routes of administration, and treatment regimens.
Research generating evidence to support restrictions on certain antimicrobials for human use.
Who can I contact for more information about the EUP OHAMR Joint Transnational Call?
You can contact Canadian Institutes of Health Research (CIHR) by email at secretariat@ohamr.eu or by phone at +46 8 546 44 000.
Where is the EUP OHAMR Joint Transnational Call available?
The EUP OHAMR Joint Transnational Call program is available across Canada.
Is the EUP OHAMR Joint Transnational Call a grant, loan, or tax credit?
EUP OHAMR Joint Transnational Call is a Grant and Funding